|
Published by: Global Markets Direct
Published: Apr. 23, 2008 - 319 Pages
Table of Contents
- 1 Table Of Contents
- 1.1 List of Tables
- 1.2 List of Figures
- 2 Introduction
- 2.1 What Is This Report About?
- 2.2 Definitions
- 2.2.1 Nephrology and Urology Devices
- 3 Healthcare Sector Review
- 3.1 Healthcare Expenditure
- 3.2 Healthcare Infrastructure
- 3.2.1 Healthcare Personnel Data
- 3.2.2 Healthcare Facilities Data
- 4 Nephrology and Urology Devices in United States
- 4.1 Nephrology and Urology Devices Overall Revenues (2000-2012)
- 4.2 Nephrology and Urology Devices Overall Volume (2000-2012)
- 4.3 Nephrology and Urology Devices Overall Company Share (2005-2006)
- 5 Incontinence Devices in United States
- 5.1 Incontinence Devices Overall Revenue (2000-2012)
- 5.1.1 Protective Garments for Incontinence Overall Revenues (2000-2012)
- 5.1.2 Urinary Catheters Overall Revenues (2000-2012)
- 5.1.3 Urine Bags Overall Revenues (2000-2012)
- 5.2 Incontinence Devices Overall Volume (2000-2012)
- 5.2.1 Protective Garments for Incontinence Overall Volume (2000-2012)
- 5.2.2 Urine Bags Overall Volume (2000-2012)
- 5.2.3 Urinary catheters Overall Volume (2000-2012)
- 5.3 Incontinence Devices Average Price (2000-2012)
- 5.3.1 Protective Garments for Incontinence Average Price (2000-2012)
- 5.3.2 Urinary Catheters Average Price (2000-2012)
- 5.3.3 Urine Bags Average Price (2000-2012)
- 5.4 Incontinence Devices Distribution Share (2005-2006)
- 5.4.1 Incontinence Devices Company Share
- 6 Renal Dialysis in United States
- 6.1 Renal Dialysis Equipment Overall Revenue (2000-2012)
- 6.1.1 Peritoneal Dialysis Solutions Overall Revenues (2000-2012)
- 6.1.2 Hemodialysis Machines Overall Revenues (2000-2012)
- 6.1.3 Continuous Renal Replacement Therapy Machines Overall Revenues (2000-2012)
- 6.1.4 Dialysis Accessories Overall Revenues (2000-2012)
- 6.2 Renal Dialysis Equipment Overall Volume (2000-2012)
- 6.2.1 Dialysis Accessories Overall Volume (2000-2012)
- 6.2.2 Continuous Renal Replacement Therapy Machines Overall Volume (2000-2012)
- 6.2.3 Hemodialysis Machines Overall Volume (2000-2012)
- 6.3 Renal Dialysis Equipment Average Price (2000-2012)
- 6.3.1 Hemodialysis Machines Average Price (2000-2012)
- 6.3.2 Continuous Renal Replacement Therapy Machines Average Price (2000-2012)
- 6.3.3 Dialysis Accessories Average Price (2000-2012)
- 6.4 Renal Dialysis Equipment Distribution Share (2005-2006)
- 6.5 Renal Dialysis Equipment Company Share (2005-2006)
- 7 Lithoripters in United States
- 7.1 Lithotripters Overall Revenue (2000-2012)
- 7.2 Lithotripters Overall Volume (2000-2012)
- 7.3 Lithotripters Average Price (2000-2012)
- 7.4 Lithotripters Distribution Share (2005-2006)
- 7.5 Lithotripters Company Share (2005-2006)
- 8 Baxter International Company Profile
- 8.1 Company Overview
- 8.2 Business Overview
- 8.2.1 BioScience
- 8.2.2 Medication Delivery
- 8.2.3 Renal
- 8.2.4 Products
- 8.2.5 History
- 8.3 Value Chain Analysis
- 8.3.1 Manufacturing
- 8.3.2 Product Development
- 8.3.3 Sales and Marketing
- 8.4 SWOT Analysis
- 8.4.1 Baxter International Inc. Strengths
- 8.4.2 Baxter International Inc. Weaknesses
- 8.4.3 Baxter International Inc. Opportunities
- 8.4.4 Baxter International Inc. Threats
- 8.5 Financial and Operational Review
- 8.6 Locations And Subsidiaries
- 8.7 Financial Deals Landscape
- 8.7.1 Baiyunshan And Baxter Form A Joint Venture In China
- 8.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration
- 8.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital
- 8.7.4 B. Braun Acquires Renal Therapy Business Of Baxter
- 8.7.5 Innovata signs a license agreement with Baxter International
- 8.7.6 Kuros Biosurgery Signs An Agreement With Baxter International
- 8.7.7 Gambro Signs An Agreement With Baxter
- 8.7.8 Baxter Healthcare And Gambro Enter Into An Agreement
- 8.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System
- 8.7.10 Baxter International And Kaketsuken Enter Into Agreement
- 8.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful
- 8.8 Recent Developments
- 8.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007
- 8.8.2 Dec 18, 2007: Baxter Elects CFO
- 8.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend
- 8.8.4 Aug 01, 2007: Baxter Elects New Board Director
- 8.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend
- 8.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization
- 8.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend
- 8.8.8 Nov 28, 2006: Baxter Announces Annual Dividend
- 8.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America
- 8.9 Baxter International Inc. Pipeline Products
- 8.9.1 Next-Generation Home Hemodialysis Machine
- 9 Kimberly-Clark Corporation Company Profile
- 9.1 Company Overview
- 9.2 Business Overview
- 9.2.1 Consumer Tissue
- 9.2.2 Healthcare
- 9.2.3 K-C Professional & Other
- 9.2.4 Personal Care
- 9.2.5 Products
- 9.2.6 History
- 9.3 Value Chain Analysis
- 9.3.1 Manufacturing
- 9.3.2 Product Development
- 9.3.3 Sales and Marketing
- 9.4 SWOT Analysis
- 9.4.1 Kimberly-Clark Corporation Strengths
- 9.4.2 Kimberly-Clark Corporation Weaknesses
- 9.4.3 Kimberly-Clark Corporation Opportunities
- 9.4.4 Kimberly-Clark Corporation Threats
- 9.5 Financial and Operational Review
- 9.6 Locations And Subsidiaries
- 9.7 Financial Deals Landscape
- 9.7.1 Kimberly-Clark Increases Its Ownership In Brazilian Affiliate To 100%
- 9.7.2 Kimberly-Clark Acquires Microcuff
- 9.7.3 Betty Mills Partners with Kimberly-Clark Professional
- 9.8 Recent Developments
- 9.8.1 Mar 06, 2008: Kimberly-Clark Announces Management Changes
- 9.8.2 Feb 21, 2008: Kimberly-Clark Approves Quarterly Dividend
- 9.8.3 Nov 14, 2007: Kimberly-Clark Declares Quarterly Dividend
- 9.8.4 Aug 01, 2007: Kimberly-Clark Declares Quarterly Dividend
- 9.8.5 Jul 25, 2007: Kimberly-Clark Elects New Board Member
- 9.8.6 Apr 26, 2007: Kimberly-Clark Declares Quarterly Dividend
- 9.8.7 Apr 02, 2007: Kimberly-Clark Announces New Global Marketing Structure
- 9.8.8 Mar 19, 2007: Kimberly-Clark Announces President
- 9.8.9 Feb 21, 2007: Kimberly-Clark Announces Increase In Dividend
- 9.8.10 Feb 15, 2007: Kimberly-Clark Announces CIO
- 9.8.11 Jan 29, 2007: Kimberly-Clark Signs Agreement With Accenture
- 9.8.12 Jan 16, 2007: Kimberly-Clark Signs Agreement With Cognizant
- 9.8.13 Jan 16, 2007: Kimberly-Clark Signs Agreement With TCS
- 9.8.14 Jan 08, 2007: Kimberly-Clark Signs Agreement With ICG Commerce
- 9.8.15 Jan 08, 2007: Kimberly-Clark Signs Contract With Genpact
- 9.8.16 Nov 15, 2006: Kimberly-Clark Elects Board Member
- 9.8.17 Nov 15, 2006: Kimberly-Clark Declares Quarterly Dividend
- 9.8.18 Sep 21, 2006: Kimberly-Clark Announces CMO
- 9.8.19 Sep 20, 2006: Kimberly-Clark To Establish Innovation Center In South Korea
- 9.8.20 Aug 01, 2006: Kimberly-Clark Declares Quarterly Dividend
- 10 Covidien Ltd./Tyco Healthcare Company Profile
- 10.1 Company Overview
- 10.2 Business Overview
- 10.2.1 Imaging Solutions
- 10.2.2 Medical Devices
- 10.2.3 Medical Supplies
- 10.2.4 Pharmaceutical Products
- 10.2.5 Retail Products
- 10.2.6 Major Products and Services
- 10.2.7 History
- 10.3 Value Chain Analysis
- 10.3.1 Manufacturing
- 10.3.2 Product Development
- 10.3.3 Sales and Marketing
- 10.4 SWOT Analysis
- 10.4.1 Covidien Ltd./Tyco Healthcare Strengths
- 10.4.2 Covidien Ltd./Tyco Healthcare Weaknesses
- 10.4.3 Covidien Ltd./Tyco Healthcare Opportunities
- 10.4.4 Covidien Ltd./Tyco Healthcare Threats
- 10.5 Financial and Operational Review
- 10.5.1 Financial Statements
- 10.5.2 Financial Ratios
- 10.5.3 Share Holding Structure
- 10.6 Locations And Subsidiaries
- 10.7 Financial Deals Landscape
- 10.7.1 Covidien Signs An Agreement With Allergan
- 10.7.2 Covidien Acquires Scandius Biomedical
- 10.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million
- 10.7.4 Covidien And BioSynthema Enter Into Licensing Agreement
- 10.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien
- 10.7.6 Covidien To Sell European Incontinence Business
- 10.7.7 Covidien To Acquire Tissue Science Laboratories
- 10.8 Recent Developments
- 10.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007
- 10.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend
- 10.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case
- 10.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results
- 10.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend
- 10.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results
- 10.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results
- 10.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent
- 10.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend
- 10.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results
- 10.9 Covidien Ltd./Tyco Healthcare Pipeline Products
- 10.9.1 PleuraSeal Lung Sealant System
- 10.9.2 Sandman Intro CPAP Device
- 11 C.R. Bard, Inc. Company Profile
- 11.1 Company Overview
- 11.2 Business Overview
- 11.2.1 Oncology Product Line
- 11.2.2 Other Products Product Line
- 11.2.3 Surgical Specialties Product Line
- 11.2.4 Urology Product Line
- 11.2.5 Vascular Product Line
- 11.2.6 Major Products and Services
- 11.2.7 History
- 11.3 Value Chain Analysis
- 11.3.1 Manufacturing
- 11.3.2 Product Development
- 11.3.3 Sales and Marketing
- 11.4 SWOT Analysis
- 11.4.1 C.R. Bard, Inc. Strengths
- 11.4.2 C.R. Bard, Inc. Weaknesses
- 11.4.3 C.R. Bard, Inc. Opportunities
- 11.4.4 C.R. Bard, Inc. Threats
- 11.5 Financial and Operational Review
- 11.5.1 Financial Statements
- 11.5.2 Financial Ratios
- 11.5.3 Share Holding Structure
- 11.6 Locations And Subsidiaries
- 11.7 Financial Deals Landscape
- 11.7.1 Edwards Lifesciences Sells LifeStent Product Line to C.R. Bard
- 11.7.2 C. R. Bard Enters Into License Agreement With Genzyme Corporation
- 11.7.3 Bard Acquires Venetec International
- 11.7.4 Bard Acquires Stent Technology Assets From PST
- 11.7.5 Bard Acquires Certain Assets From Genyx Medical
- 11.7.6 CONMED Acquires Endoscopic Technologies Product Line From C.R. Bard
- 11.7.7 C. R. Bard Acquires Assets Of Onux Medical
- 11.7.8 Tissue Science Laboratories Enters Into Agreement With C.R. Bard
- 11.7.9 C. R. Bard To Acquire Specialized Health Products International
- 11.8 Recent Developments
- 11.8.1 Jan 31, 2008: Bard Reports Q4 2007 Results
- 11.8.2 Dec 12, 2007: Bard Announces Patent Infringement Verdict Against W. L. Gore
- 11.8.3 Dec 12, 2007: Bard Declares Quarterly Dividend
- 11.8.4 Oct 23, 2007: Bard Reports Q3 2007 Results
- 11.8.5 Oct 10, 2007: Bard Announces Share Repurchase Program
- 11.8.6 Oct 10, 2007: Bard Declares Quarterly Dividend
- 11.8.7 Jul 24, 2007: Bard Reports Q2 2007 Results
- 11.8.8 Jun 13, 2007: Bard Declares Quarterly Dividend
- 11.8.9 Apr 24, 2007: Bard Reports Q1 2007 Results
- 11.8.10 Apr 18, 2007: Bard Declares Quarterly Dividend
- 11.8.11 Jan 25, 2007: Bard Reports Q4 2006 Results
- 11.9 C.R. Bard, Inc. Pipeline Products
- 11.9.1 VIVEXX Carotid Stent
- 11.9.2 Bard Pulsed RF Ablation System
- 11.9.3 BARD HD MESH Ablation System
- 11.9.4 Bard Scorpion Ablation Catheter
- 11.9.5 BARD HD MESH Mapper Catheter
- 12 Fresenius Medical Care AG & Co. KGaA Company Profile
- 12.1 Company Overview
- 12.2 Business Overview
- 12.2.1 Dialysis Care Segment
- 12.2.2 Dialysis Products Segment
- 12.2.3 Major Products and Services
- 12.2.4 History
- 12.3 Value Chain Analysis
- 12.3.1 Manufacturing
- 12.3.2 Product Development
- 12.3.3 Sales and Marketing
- 12.4 SWOT Analysis
- 12.4.1 Fresenius Medical Care AG & Co. KGaA Strengths
- 12.4.2 Fresenius Medical Care AG & Co. KGaA Weaknesses
- 12.4.3 Fresenius Medical Care AG & Co. KGaA Opportunities
- 12.4.4 Fresenius Medical Care AG & Co. KGaA Threats
- 12.5 Financial and Operational Review
- 12.5.1 Financial Statements
- 12.5.2 Financial Ratios
- 12.6 Locations And Subsidiaries
- 12.7 Financial Deals Landscape
- 12.7.1 Fresenius Medical Acquires Renal Solutions
- 12.7.2 Fresenius Medical Care Completes Private Placement
- 12.7.3 Fresenius Completes Acquisition Of The Phosphate Binder Business From Nabi Biopharmaceuticals
- 12.7.4 Fresenius Medical Care Acquires Renal Care Group
- 12.8 Recent Developments
- 12.8.1 Mar 06, 2008: Fresenius Expands Dialyzer Production Capacity In Germany
- 12.8.2 Feb 20, 2008: Fresenius Medical Declares Q4 2007 Results
- 12.8.3 Oct 31, 2007: Fresenius Medical Declares Q3 2007 Results
- 12.8.4 Aug 02, 2007: Fresenius Medical Declares Q2 2007 Results
- 12.8.5 May 15, 2007: Fresenius Medical Announces Share Split Approval
- 12.8.6 May 02, 2007: Fresenius Medical Declares Q1 2007 Results
- 12.8.7 Feb 22, 2007: Fresenius Medical Declares Q4 2006 Results
- 12.8.8 Oct 31, 2006: Fresenius Medical Declares Q3 2006 Results
- 13 Regulation System
- 13.1 Medical Equipment Approval Process
- 13.1.1 Pre-market Approval Process
- 13.1.2 Intended use and Indications for use
- 13.1.3 Predicate Device
- 13.1.4 Safe and Effective
- 13.1.5 Other Category Devices
- 13.1.6 Post-Market Approval Process
- 13.1.7 Compliance and Enforcement
- 13.1.8 Registration Fee
- 13.1.9 Approval Time
- 14 Pricing and Reimbursement
- 14.1 Government Policies
- 14.2 Private Insurance
- 14.3 Diagnosis Related Groups (DRG)
- 15 Distribution Structure
- 15.1 Distribution Structure
- 16 APPENDIX
- 16.1 Methodology
- 16.2 Coverage
- 16.3 Secondary Research
- 16.4 Primary Research
- 16.5 Models
- 16.6 Forecasts
- 16.7 Expert Panels
- 16.8 Contact Us
- 16.9 Disclaimer
AbstractUnited States Nephrology & Urology Devices Medical Equipment Industry Report
Summary
This report is an essential source for in-depth information and data relating to United States Nephrology & Urology devices medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the Nephrology & Urology devices medical equipment in United States.
Scope- The report provides sector information broken down into detailed categories and segments in country.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.
Note: Some content types may not be available in this report
Reasons to buy - Gain a strong understanding of the industry at a global level, with break downs for the country
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|
